生命科学资讯

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus - ts2.tech

HHS urges Supreme Court to decline AstraZeneca's petition over Medicare price negotiations

Unpleasant Surprises Could Be In Store For Thermo Fisher Scientific Inc.'s (NYSE:TMO) Shares - simplywall.st

US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups

Why 10x Genomics Stock Is Quietly Climbing - TipRanks

Agilent Technologies (A) Upgraded to Outperform by Evercore ISI Group | A Stock News - GuruFocus

Agilent Technologies (A) Upgraded to Outperform by Evercore ISI Group | A Stock News - GuruFocus

Thermo Fisher Scientific wins three R&D 100 Awards for innovations accelerating drug development - R&D World

Crinetics reports robust full-quarter sales for rare disease drug Palsonify

Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026

Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $650 From $610, Maintains Outperform Rating - marketscreener.com

US vaccine schedule slashed to international standards

Appointments and advancements for Jan. 5, 2026

Financings for Jan. 5, 2026

Other news to note for Jan. 5, 2026

Regulatory actions for Jan. 5, 2026

Moderna, searching for a rebound, to seek approval of mRNA flu shot

Zenas shares crash after top drug misses expectations in immune disease study

Zenas BioPharma’s Phase 3 autoimmune disease readout disappoints

Citi Maintains 10x Genomics(TXG.US) With Hold Rating - 富途牛牛